Aberdeen Asset Management plc Price Target Lowered to GBX 470 at Credit Suisse (ADN)
Analysts at Credit Suisse decreased their price target on shares of Aberdeen Asset Management plc (LON:ADN) from GBX 515 ($8.45) to GBX 470 ($7.72) in a research report issued to clients and investors on Monday, StockRatingsNetwork.com reports. The firm currently has a “neutral” rating on the stock. Credit Suisse’s target price would suggest a potential upside of 7.06% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at UBS AG cut their price target on shares of Aberdeen Asset Management plc from GBX 540 ($8.86) to GBX 520 ($8.54) in a research note to investors on Friday. They now have a “buy” rating on the stock. Separately, analysts at RBC Capital reiterated an “outperform” rating on shares of Aberdeen Asset Management plc in a research note to investors on Thursday. Finally, analysts at Societe Generale reiterated a “buy” rating on shares of Aberdeen Asset Management plc in a research note to investors on Thursday. They now have a GBX 465 ($7.63) price target on the stock. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and fifteen have given a buy rating to the company’s stock. Aberdeen Asset Management plc presently has an average rating of “Buy” and an average price target of GBX 551.17 ($9.05).
Shares of Aberdeen Asset Management plc (LON:ADN) opened at 436.80 on Monday. Aberdeen Asset Management plc has a one year low of GBX 342.60 and a one year high of GBX 500.00. The stock’s 50-day moving average is GBX 471.0 and its 200-day moving average is GBX 419.2. The company’s market cap is £5.016 billion.
Aberdeen Asset Management PLC is an international asset management company investing across the four main asset classes of equity, fixed income, property and alternative investment strategies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.